NCT05921578 Cone-beam CT in the Diagnosis and Surgical Treatment of Otosclerosis.
| NCT ID | NCT05921578 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rigshospitalet, Denmark |
| Condition | Otosclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-05-17 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-05-17 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Our studies will systematically investigate and establish evidence on whether Cone-beam computed tomography (CBCT) of the temporal bone could be used in the diagnosis and treatment of otosclerosis and in the post-operative follow-up after stapedotomy.
Eligibility Criteria
Inclusion Criteria: * Adults (\>18 years of age). * Referred to our department suspected for otosclerosis. * Consents to participation in the project. Exclusion Criteria: * A history of surgical treatment for otosclerosis (ipsilateral ear). * A history of tympanoplasty type 2-4 (ipsilateral ear). * Other competing middle-ear diseases (ipsilateral ear). Inclusion and exclusion criteria for patients enrolled for post-surgical follow-up are the same as above in addition to: Exclusion: \- Intraoperative findings not supporting otosclerosis.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05921578 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Otosclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05921578 currently recruiting?
Yes, NCT05921578 is actively recruiting participants. Contact the research team at bilal.hussain.akram@regionh.dk for enrollment information.
Where is the NCT05921578 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT05921578 clinical trial?
NCT05921578 is sponsored by Rigshospitalet, Denmark. The trial plans to enroll 100 participants.